Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
interferon gamma | 0.288 | 0.962 | 0.47 |
|
phenotype | 0.100 | None | 0.909 | 33 | 0 | 1989 | 2019 | ||||||||
|
BCL2 apoptosis regulator | 0.291 | 0.885 | 0.56 |
|
phenotype | 0.100 | None | 0.925 | 105 | 0 | 1995 | 2020 | ||||||||
|
phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha | 0.292 | 0.923 | 1.00 |
|
phenotype | 0.400 | None | 0.976 | 290 | 3 | 2003 | 2020 | ||||||||
|
epidermal growth factor receptor | 0.295 | 0.885 | 0.37 |
|
phenotype | 0.400 | None | 0.973 | 512 | 10 | 1988 | 2020 | ||||||||
|
C-reactive protein | 0.299 | 0.962 | 3.7E-03 |
|
phenotype | 0.100 | None | 0.955 | 22 | 2 | 2009 | 2019 | ||||||||
|
cyclin dependent kinase inhibitor 2A | 0.300 | 0.885 | 0.39 |
|
phenotype | 0.100 | None | 0.942 | 137 | 2 | 1992 | 2020 | ||||||||
|
catenin beta 1 | 0.303 | 0.885 | 1.00 |
|
phenotype | 0.400 | None | 0.962 | 313 | 1 | 1996 | 2020 | ||||||||
|
matrix metallopeptidase 9 | 0.305 | 0.923 | 1.9E-17 |
|
phenotype | 0.600 | None | 0.991 | 428 | 4 | 1996 | 2020 | ||||||||
|
phosphatase and tensin homolog | 0.305 | 0.923 | 0.26 |
|
phenotype | 0.400 | None | 0.976 | 162 | 1 | 1997 | 2020 | ||||||||
|
C-X-C motif chemokine ligand 8 | 0.310 | 0.962 | 2.7E-04 |
|
phenotype | 0.100 | None | 0.986 | 138 | 0 | 1994 | 2020 | ||||||||
|
AKT serine/threonine kinase 1 | 0.311 | 0.962 | 0.98 |
|
phenotype | 0.100 | None | 1.000 | 216 | 2 | 2002 | 2020 | ||||||||
|
prostaglandin-endoperoxide synthase 2 | 0.314 | 0.962 | 1.00 |
|
phenotype | 0.600 | None | 0.968 | 139 | 0 | 1998 | 2020 | ||||||||
|
albumin | 0.317 | 0.962 | 0.64 |
|
phenotype | 0.100 | None | 1.000 | 21 | 0 | 1994 | 2020 | ||||||||
|
insulin like growth factor 1 | 0.318 | 0.885 | 0.27 |
|
phenotype | 0.400 | None | 1.000 | 61 | 1 | 1997 | 2019 | ||||||||
|
B-Raf proto-oncogene, serine/threonine kinase | 0.319 | 0.846 | 1.00 |
|
phenotype | 0.100 | None | 0.932 | 278 | 6 | 2003 | 2020 | ||||||||
|
phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta | 0.319 | 0.885 | 1.00 |
|
phenotype | 0.100 | None | 0.987 | 230 | 1 | 2004 | 2020 | ||||||||
|
signal transducer and activator of transcription 3 | 0.320 | 0.923 | 1.00 |
|
phenotype | 0.400 | None | 0.996 | 246 | 0 | 2001 | 2020 | ||||||||
|
phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma | 0.320 | 0.885 | 1.4E-06 |
|
phenotype | 0.100 | None | 0.987 | 236 | 0 | 2004 | 2020 | ||||||||
|
KRAS proto-oncogene, GTPase | 0.320 | 0.923 | 7.9E-04 |
|
phenotype | 0.400 | None | 0.952 | 207 | 7 | 1991 | 2020 | ||||||||
|
C-C motif chemokine ligand 2 | 0.321 | 0.962 | 0.61 |
|
phenotype | 0.100 | None | 0.983 | 60 | 0 | 1995 | 2020 | ||||||||
|
toll like receptor 4 | 0.321 | 0.962 | 4.6E-09 |
|
phenotype | 0.400 | None | 1.000 | 35 | 2 | 2009 | 2020 | ||||||||
|
phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta | 0.322 | 0.885 | 1.00 |
|
phenotype | 0.100 | None | 0.987 | 231 | 1 | 2004 | 2020 | ||||||||
|
single-strand-selective monofunctional uracil-DNA glycosylase 1 | 0.322 | 0.923 | 4.5E-04 |
|
phenotype | 0.100 | None | 0.984 | 125 | 0 | 2017 | 2020 | ||||||||
|
estrogen receptor 1 | 0.324 | 0.962 | 1.00 |
|
phenotype | 0.400 | None | 0.962 | 228 | 3 | 1992 | 2020 | ||||||||
|
CD274 molecule | 0.324 | 0.923 | 1.9E-02 |
|
phenotype | 0.100 | None | 0.954 | 173 | 0 | 2011 | 2020 |